BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37605497)

  • 1. Epigenetic Regulation of the Expression of T Cell Stimulatory and Inhibitory Factors by Histone H3 Lysine Modification Enzymes and Its Prognostic Roles in Glioblastoma.
    Lee SH; Kim SH; Nam TM; Jang JH; Kim KH; Lee YS; Kim MS; Kim MS; Jin SY; Lee M; Lee SH; Kim YZ
    J Korean Med Sci; 2023 Aug; 38(33):e258. PubMed ID: 37605497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
    Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
    J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma.
    Lee SH; Lee EH; Lee SH; Lee YM; Kim HD; Kim YZ
    J Korean Med Sci; 2015 Aug; 30(8):1157-66. PubMed ID: 26240495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.
    Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E
    Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
    Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
    Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas.
    Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer.
    Sasidharan Nair V; Toor SM; Taha RZ; Shaath H; Elkord E
    Clin Epigenetics; 2018 Aug; 10(1):104. PubMed ID: 30081950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of CD28-CTLA4-PD-L1 Costimulatory Molecules Reduces Herpes Simplex Virus 1 Reactivation.
    Matundan HH; Jaggi U; Yu J; Akbari O; Ghiasi H
    mBio; 2021 Aug; 12(4):e0117621. PubMed ID: 34281386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of immune checkpoint regulators in interferon γ induced urothelial carcinoma and activated T-lymphocyte cells by cytostatics.
    Hänze J; Schulte-Herbrüggen J; Hofmann R; Hegele A
    Genes Immun; 2023 Jun; 24(3):149-153. PubMed ID: 37138100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome.
    Hodge G; Hodge S; Ahern J; Holmes-Liew CL; Reynolds PN; Holmes M
    Clin Exp Immunol; 2013 Jul; 173(1):150-60. PubMed ID: 23607447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis.
    Lee JH; Kim YJ; Ryu HW; Shin SW; Kim EJ; Shin SH; Park JY; Kim SY; Hwang CS; Na JY; Shin DH; Kim JY; Lee HJ
    Diagn Pathol; 2023 Mar; 18(1):36. PubMed ID: 36894965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the B7 family of co-stimulatory molecules: successes and challenges.
    Podojil JR; Miller SD
    BioDrugs; 2013 Feb; 27(1):1-13. PubMed ID: 23329394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The landscape of
    de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D
    Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma.
    Kim HG; Kim MS; Lee YS; Lee EH; Kim DC; Lee SH; Kim YZ
    Cancer Res Treat; 2022 Jul; 54(3):690-708. PubMed ID: 34793663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
    Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G
    J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients.
    Karimi MH; Motazedian M; Abedi F; Yaghobi R; Geramizadeh B; Nikeghbalian S
    Gene; 2012 Aug; 504(1):127-32. PubMed ID: 22579879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.
    Tokić S; Štefanić M; Karner I; Glavaš-Obrovac L
    Endokrynol Pol; 2017; 68(3):274-828. PubMed ID: 28660994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.